JMJean-Michel MolinaMD, PhDVideoHIVRSVManaging HIV Patients with Limited Treatment Options - EU Series 2022Managing HIV Patients with Limited Treatment Options - French Edition, Session 1View Video
AHAnnette HaberlMD VideoHIVRSVManaging HIV Patients with Limited Treatment Options - EU Series 2022Managing HIV Patients with Limited Treatment Options - German Edition (Part Two)View Video
JRJürgen RockstrohMDVideoHIVRSVManaging HIV Patients with Limited Treatment Options - EU Series 2022Managing HIV Patients with Limited Treatment Options - German Edition | Georg Behrens, MD, PhDView Video
WLWei LyuPhDVideoHIVChinese HIV Clinical Forum 2022Clinical Case (focused on starting and switching therapy) - Wei Lyu, PhDView Video
JMJean-Michel MolinaMD, PhDSlidesetHIVChinese HIV Clinical Forum 2022Jean-Michel Molina - Update on Long Acting Therapeutic Options for HIV TreatmentView Slideset
ACAndrea CalcagnoMD, DTM&HSlidesetHIVChinese HIV Clinical Forum 2022Andrea Calgano - Pharmacological Considerations in Choice of RegimenView Slideset
WLWei LyuPhDSlidesetHIVChinese HIV Clinical Forum 2022Wei Lyu - Clinical Case (focused on starting and switching therapy)View Slideset
FZFujie ZhangMD, PhDSlidesetHIVChinese HIV Clinical Forum 2022Fujie Zhang - HIV Low-Level Viremia and New Approach to Drug Resistance SurveillanceView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVChinese HIV Clinical Forum 2022Marta Boffito - Stopping/Switching Considerations When Using La-ARVsView Slideset
LDLili DaiPhDSlidesetHIVChinese HIV Clinical Forum 2022Lili Dai - Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled TrialView Slideset
LDLili DaiPhDVideoHIVChinese HIV Clinical Forum 2022Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled Trial - Lili Dai, PhDView Video
CHChien-Ching HungMD, PhDVideoHIVChinese HIV Clinical Forum 2022International Data Supporting Rapid Start - Chien-Ching Hung, MD, PhDView Video
